IO Biotech | SC 13D/A:超過5%持股股東披露文件(修正)-Novo Holdings A/S(8.5%)
IO Biotech | 4:持股變動聲明-股東 Novo Holdings A/S
IO Biotech | 4:持股變動聲明-董事 Hunter Heidi
IO Biotech | 4:持股變動聲明-董事 Smith David V
IO Biotech | 4:持股變動聲明-董事 Hirth Peter
IO Biotech | 4:持股變動聲明-董事 Glaub Kathleen Sereda
IO Biotech | 4:持股變動聲明-董事 Elling Christian E
IO Biotech | 4:持股變動聲明-董事 Collins Helen Louise
IO Biotech | SC 13G/A:超過5%持股股東披露文件(修正)-Novo Holdings A/S(10.1%)
IO Biotech | 4:持股變動聲明-股東 Novo Holdings A/S
IO Biotech | 4:持股變動聲明-高管 Zocca Mai-Britt
IO Biotech | 4:持股變動聲明-高管 Smith Devin Whittemore
IO Biotech | 4:持股變動聲明-高管 Sullivan Amy
IO Biotech | 4:持股變動聲明-高管 Burkavage Brian
IO Biotech | 4:持股變動聲明-高管 Ahmad Qasim Iftikhar
IO Biotech | SC 13G/A:超過5%持股股東披露文件(修正)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)
IO Biotech | SC 13D/A:超過5%持股股東披露文件(修正)-Novo Holdings A/S(11.1%)
IO Biotech | 4:持股變動聲明-股東 Novo Holdings A/S
IO Biotech | SC 13G/A:超過5%持股股東披露文件(修正)-BANK OF AMERICA CORPORATION(2.8%)
IO Biotech | SC 13G/A:超過5%持股股東披露文件(修正)-HBM Healthcare Investments (Cayman) Ltd.(6.0%)
暫無數據
暫無數據